Babcock & Wilcox has picked Daniel E. Glenn, a Department of Energy official, to lead research and development for its medical-isotope initiative, which might lead to the establishment of an isotope-production facility in Lynchburg, Va., within a few years. The initiative will employ B&W’s patented reactor that would use low-enriched uranium to produce molybdenum-99.
Join us as a member
Filled out our membership form and join CARS Membership today for more radiopharmaceutical and scientific knowledge.